Our primary research interest is to understand the role and the underlying mechanisms of heparan sulfate proteoglycans in angiogenesis, stem cell, hemostasis and leukoctye trafficking/inflammation with a long-term goal to develop novel therapeutics to improve the treatment of vascular diseases such as ischemia and stroke, inflamation and cancer et al. 

Funding: 
Supports from NIH (R01, R21, P41), Georgia Research Coalition and Am. Heart Association